1. Home
  2. NLSP vs RCAT Comparison

NLSP vs RCAT Comparison

Compare NLSP & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • RCAT
  • Stock Information
  • Founded
  • NLSP 2015
  • RCAT 2002
  • Country
  • NLSP Switzerland
  • RCAT United States
  • Employees
  • NLSP N/A
  • RCAT N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • RCAT Wholesale Distributors
  • Sector
  • NLSP Health Care
  • RCAT Industrials
  • Exchange
  • NLSP Nasdaq
  • RCAT Nasdaq
  • Market Cap
  • NLSP 5.2M
  • RCAT 248.8M
  • IPO Year
  • NLSP 2021
  • RCAT 2017
  • Fundamental
  • Price
  • NLSP $1.95
  • RCAT $10.72
  • Analyst Decision
  • NLSP
  • RCAT Strong Buy
  • Analyst Count
  • NLSP 0
  • RCAT 1
  • Target Price
  • NLSP N/A
  • RCAT $4.00
  • AVG Volume (30 Days)
  • NLSP 535.3K
  • RCAT 12.1M
  • Earning Date
  • NLSP 12-31-2024
  • RCAT 12-16-2024
  • Dividend Yield
  • NLSP N/A
  • RCAT N/A
  • EPS Growth
  • NLSP N/A
  • RCAT N/A
  • EPS
  • NLSP N/A
  • RCAT N/A
  • Revenue
  • NLSP N/A
  • RCAT $16,468,647.00
  • Revenue This Year
  • NLSP N/A
  • RCAT $125.47
  • Revenue Next Year
  • NLSP N/A
  • RCAT $167.75
  • P/E Ratio
  • NLSP N/A
  • RCAT N/A
  • Revenue Growth
  • NLSP N/A
  • RCAT 95.46
  • 52 Week Low
  • NLSP $1.73
  • RCAT $0.56
  • 52 Week High
  • NLSP $24.32
  • RCAT $12.57
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 34.15
  • RCAT 59.10
  • Support Level
  • NLSP $1.73
  • RCAT $7.76
  • Resistance Level
  • NLSP $2.79
  • RCAT $9.99
  • Average True Range (ATR)
  • NLSP 0.36
  • RCAT 1.35
  • MACD
  • NLSP 0.04
  • RCAT -0.09
  • Stochastic Oscillator
  • NLSP 14.67
  • RCAT 62.99

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a military technology company that integrates robotic hardware and software to provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders. Its mission is to enhance the effectiveness and safety of military operations domestically and globally. Red Cat's suite of solutions includes Teal Drones, developer of the Golden Eagle, a small unmanned system with the highest resolution imaging for night-time operations, and Skypersonic, a provider of unmanned aircraft for interior spaces and other dangerous environments.

Share on Social Networks: